A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China.
Objective: To develop a multi‐stakeholder, consensus‐based decision support framework for prioritizing innovative anticancer drugs in Chinese hospital formularies, balancing clinical benefit, patient access, and financial sustainability. Methods: A two‐round Delphi survey was conducted with a multid...
| Published in: | Health Expectations Vol. 29; no. 2; pp. 1 - 10 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Wiley-Blackwell
Apr2026
|
| Online Access: | View this record in EBSCOhost |